Form 4: Axogen CFO Sells Shares After Option Exercise

Axogen's CFO, Lindsey Marie Hartley, executed a pre-planned transaction, exercising stock options and subsequently selling 14,812 shares of common stock.

Summary

• Axogen, Inc.'s Chief Financial Officer, Lindsey Marie Hartley, reported transactions on December 15, 2025.
• Hartley exercised employee stock options to acquire 14,812 shares of common stock at an exercise price of $8.27 per share.
• Concurrently, Hartley sold 14,812 shares of Axogen common stock at a weighted average sale price of $29.8605 per share.
• The sale price for these shares ranged from $29.860 to $29.875 per share.
• Following these transactions, Hartley directly beneficially owns 31,376 shares of Axogen common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider transaction (exercise and sell) which is neutral in sentiment. It reflects the CFO realizing value from equity compensation but does not indicate a change in company fundamentals or outlook.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating it was pre-planned and not based on immediate, non-public information.
• The significant difference between the option exercise price ($8.27) and the sale price ($29.8605) reflects a substantial gain for the CFO, demonstrating the value appreciation of the company's stock.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market, although it is often for personal financial management or tax planning.

Future Outlook

The remaining unexercised portion of the employee stock option will continue to vest, with an additional 12.5% of the aggregate shares vesting every six months, leading to full vesting by March 16, 2027.

Industry Context

This filing reports a routine insider transaction for Axogen, Inc., a company operating in the medical device or regenerative medicine sector. Such transactions are common for executives managing their equity compensation and personal finances, often executed under pre-arranged plans.

Stakeholder Impact

• Shareholders: Minor impact. The sale represents a small portion of the company's outstanding shares and was pre-planned, suggesting no immediate change in company prospects.
• Management: The CFO is realizing value from her compensation package.

Next Steps

• Continued vesting of remaining employee stock options for Lindsey Marie Hartley, with full vesting by March 16, 2027.

Key Dates

Keywords

Axogen, AXGN, Insider Trading, Form 4, Stock Option Exercise, Share Sale, CFO, Lindsey Hartley, Beneficial Ownership